A Rollover Study to Provide Chronic T-1249 to Patients Who Completed Study T1249-102 - Tabular View

Tracking Information
First Received Date ^ICMJE	October 28, 2002
Last Updated Date	June 23, 2005
Start Date ^ICMJE
Primary Completion Date
Current Primary Outcome Measures ^ICMJE
Original Primary Outcome Measures ^ICMJE
Change History	Complete list of historical versions of study NCT00048217 on ClinicalTrials.gov Archive Site
Current Secondary Outcome Measures ^ICMJE
Original Secondary Outcome Measures ^ICMJE

Descriptive Information
Brief Title ^ICMJE	A Rollover Study to Provide Chronic T-1249 to Patients Who Completed Study T1249-102
Official Title ^ICMJE
Brief Summary	Patients who complete study T1249-102 (must be currently failing a T-20 containing regimen to participate in this study) will receive T-1249 at a dose of 200mg daily in combination with a background antiretroviral regimen for 96 weeks. Only patients that participated in study T1249-102 can participate in study T1249-105.
Detailed Description
Study Phase	Phase I, Phase II
Study Type ^ICMJE	Interventional
Study Design ^ICMJE	Treatment, Randomized, Open Label
Condition ^ICMJE	HIV Infections
Intervention ^ICMJE	Drug: T-1249
Study Arms / Comparison Groups
Publications *
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information
Recruitment Status ^ICMJE	Active, not recruiting
Enrollment ^ICMJE
Completion Date
Primary Completion Date
Eligibility Criteria ^ICMJE	Inclusion Criteria: Completion T1249-102; Currently failing a T-20 containing regimen Exclusion Criteria: Non-completion of T1249-102.
Gender	Both
Ages	18 Years and older
Accepts Healthy Volunteers	No
Contacts ^ICMJE	Contact information is only displayed when the study is recruiting subjects
Location Countries ^ICMJE	United States

Administrative Information
NCT ID ^ICMJE	NCT00048217
Responsible Party
Study ID Numbers ^ICMJE	T1249-105
Study Sponsor ^ICMJE	Trimeris
Collaborators ^ICMJE
Investigators ^ICMJE
Information Provided By	Trimeris
Verification Date	July 2004
^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP